TY - JOUR
T1 - Breast cancer in Mexico
T2 - A growing challenge to health and the health system
AU - Chávarri-Guerra, Yanin
AU - Villarreal-Garza, Cynthia
AU - Liedke, Pedro E.R.
AU - Knaul, Felicia
AU - Mohar, Alejandro
AU - Finkelstein, Dianne M.
AU - Goss, Paul E.
N1 - Funding Information:
PEG, DMF, PERL, and YC-G thank the Avon Foundation New York. We thank the National Council of Science and Technology (CONACYT) for their finacial support to breast-cancer research ( grant number 85055 , Sector Research Fund for Education), and Gustavo Nigenda and Hector Arreola for reviewing the manuscript.
Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2012/8
Y1 - 2012/8
N2 - Breast cancer is a major public health issue in low-income and middle-income countries. In Mexico, incidence and mortality of breast cancer have risen in the past few decades. Changes in health-care policies in Mexico have incorporated programmes for access to early diagnosis and treatment of this disease. This Review outlines the status of breast cancer in Mexico, regarding demographics, access to care, and strategies to improve clinical outcomes. We identify factors that contribute to the existing disease burden, such as low mammography coverage, poor quality control, limited access to diagnosis and treatment, and insufficient physical and human resources for clinical care.
AB - Breast cancer is a major public health issue in low-income and middle-income countries. In Mexico, incidence and mortality of breast cancer have risen in the past few decades. Changes in health-care policies in Mexico have incorporated programmes for access to early diagnosis and treatment of this disease. This Review outlines the status of breast cancer in Mexico, regarding demographics, access to care, and strategies to improve clinical outcomes. We identify factors that contribute to the existing disease burden, such as low mammography coverage, poor quality control, limited access to diagnosis and treatment, and insufficient physical and human resources for clinical care.
UR - http://www.scopus.com/inward/record.url?scp=84864366243&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864366243&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(12)70246-2
DO - 10.1016/S1470-2045(12)70246-2
M3 - Review article
C2 - 22846838
AN - SCOPUS:84864366243
VL - 13
SP - e335-e343
JO - The Lancet Oncology
JF - The Lancet Oncology
SN - 1470-2045
IS - 8
ER -
